JP2011510075A5 - - Google Patents

Download PDF

Info

Publication number
JP2011510075A5
JP2011510075A5 JP2010544334A JP2010544334A JP2011510075A5 JP 2011510075 A5 JP2011510075 A5 JP 2011510075A5 JP 2010544334 A JP2010544334 A JP 2010544334A JP 2010544334 A JP2010544334 A JP 2010544334A JP 2011510075 A5 JP2011510075 A5 JP 2011510075A5
Authority
JP
Japan
Prior art keywords
ginsenoside
subject
ginsenoside composition
composition according
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010544334A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011510075A (ja
JP5523348B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/000431 external-priority patent/WO2009094177A1/en
Publication of JP2011510075A publication Critical patent/JP2011510075A/ja
Publication of JP2011510075A5 publication Critical patent/JP2011510075A5/ja
Application granted granted Critical
Publication of JP5523348B2 publication Critical patent/JP5523348B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010544334A 2008-01-24 2009-01-23 プロトパナキサジオール系ジンセノサイド組成物及びその使用 Expired - Fee Related JP5523348B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2331008P 2008-01-24 2008-01-24
US61/023,310 2008-01-24
PCT/US2009/000431 WO2009094177A1 (en) 2008-01-24 2009-01-23 Protopanaxadiol-type ginsenoside compositions and uses thereof

Publications (3)

Publication Number Publication Date
JP2011510075A JP2011510075A (ja) 2011-03-31
JP2011510075A5 true JP2011510075A5 (https=) 2012-03-08
JP5523348B2 JP5523348B2 (ja) 2014-06-18

Family

ID=40578016

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010544334A Expired - Fee Related JP5523348B2 (ja) 2008-01-24 2009-01-23 プロトパナキサジオール系ジンセノサイド組成物及びその使用

Country Status (13)

Country Link
US (1) US8440632B2 (https=)
EP (1) EP2254569B1 (https=)
JP (1) JP5523348B2 (https=)
KR (2) KR101648987B1 (https=)
CN (1) CN101977600B (https=)
AU (1) AU2009206753B2 (https=)
CA (1) CA2713104C (https=)
DK (1) DK2254569T3 (https=)
ES (1) ES2400491T3 (https=)
MY (1) MY160074A (https=)
NZ (1) NZ587134A (https=)
TW (1) TWI440463B (https=)
WO (1) WO2009094177A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5563285B2 (ja) * 2009-12-14 2014-07-30 ライオン株式会社 飲食品、医薬品、又は医薬部外品、並びに、プロトパナキサトリオールの安定化方法、及びプロトパナキサジオールの安定化方法
WO2013078371A2 (en) 2011-11-22 2013-05-30 The Johns Hopkins University Methods and compositions for reducing alcohol toxicity
KR101446743B1 (ko) * 2012-06-11 2014-10-01 한국생명공학연구원 실리마린을 유효성분으로 포함하는 알콜성 위궤양 예방 및 치료용 조성물
CN102727508B (zh) * 2012-07-15 2014-09-24 浙江大学 人参二醇皂苷组分制备及在防治帕金森氏病中的药物用途
US11338120B2 (en) 2012-08-29 2022-05-24 Palo Alto Investors LP Methods and devices for treating parasympathetic bias mediated conditions
WO2014178803A1 (en) * 2013-04-29 2014-11-06 Alkoçlar Erdal Can A composition for use in the treatment of alcohol addiction
KR101621356B1 (ko) * 2014-09-05 2016-05-17 한국과학기술원 진세노사이드 f2의 간 질환 예방 또는 치료 용도
WO2016066189A1 (en) * 2014-10-28 2016-05-06 Robust Seed Technology A&F Aktiebolag Improved method for seed priming
US10420756B2 (en) * 2015-03-26 2019-09-24 Sen-Jam Pharmaceutical Llc. Methods and compositions to inhibit symptoms associated with veisalgia
KR101641477B1 (ko) * 2016-01-19 2016-07-20 이국진 홍삼 추출물을 이용한 커피나무의 재배방법
CN106619669B (zh) * 2016-12-02 2019-03-29 延边大学 原人参二醇皂苷在制备防治炎症疾病的药物中的应用
CN106511360A (zh) * 2016-12-02 2017-03-22 上海芮范生物科技有限公司 一种含有人参皂苷Rg3和水飞蓟素的组合物及药物
CN112274524A (zh) * 2017-08-24 2021-01-29 浙江大学 人参二醇皂苷Rb组分在制备防治代谢紊乱相关疾病药物中的应用
KR102053208B1 (ko) * 2018-03-15 2019-12-06 숙명여자대학교 산학협력단 진세노사이드 Rb1 및 Rb2를 유효성분으로 함유하는 근육 재생용 조성물
KR102138252B1 (ko) * 2018-05-16 2020-07-29 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 효모의 nadph 관련 생합성 경로의 개량을 통한 진세노사이드 생산 증대
CN111053782B (zh) * 2018-10-17 2024-07-05 株式会社爱茉莉太平洋 包含人参皂苷的组合物
KR102672902B1 (ko) * 2018-10-31 2024-06-10 (주)아모레퍼시픽 신규 진세노사이드를 포함하는 숙취 해소용 조성물
US11000538B2 (en) * 2018-10-31 2021-05-11 Amorepacific Corporation Composition for enhancing exercise ability or anti-fatigue comprising novel ginsenoside
CN109758464B (zh) * 2019-03-21 2019-10-25 淮阴师范学院 越南人参皂苷r4在制备神经退行性疾病治疗药物中的应用
WO2021069615A1 (en) 2019-10-10 2021-04-15 Zobrius Pharma As Improved anti-hangover composition, its preparation and uses
KR102654669B1 (ko) * 2021-06-30 2024-04-04 경희대학교 산학협력단 실리디아닌을 포함하는 인삼 금 나노에멀젼 및 이의 용도

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1574806A (en) 1976-06-03 1980-09-10 Inverni Della Beffa Spa Production of purified ginseng extracts and pharmaceutical compositions containing the extracts
US4966893A (en) 1989-01-13 1990-10-30 Pang Peter K T Method for treatment of senile dementia
JPH04316448A (ja) 1991-04-12 1992-11-06 Iwatani Internatl Corp 人参微粉末の製造方法
US5547671A (en) 1995-09-20 1996-08-20 Duthinh; Phu Anti-intoxication composition
JP3656972B2 (ja) * 1997-02-14 2005-06-08 丸善製薬株式会社 アルコール臭低減剤
US6083932A (en) 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same
US6156291A (en) 1997-08-28 2000-12-05 Cv Technologies Inc. Chemical and pharmacological standardization of herbal extracts
KR20020035855A (ko) 1999-08-30 2002-05-15 마쯔오 미쯔요시 약용인삼을 포함하는 뇌세포 또는 신경세포 보호제
CA2307393A1 (en) 2000-05-01 2001-11-01 The University Of British Columbia Ginsenoside chemotherapy
CN1167424C (zh) * 2000-11-18 2004-09-22 唐修文 三七人参皂甙肠溶片
US7011096B2 (en) * 2001-08-31 2006-03-14 Philip Morris Usa Inc. Oxidant/catalyst nanoparticles to reduce carbon monoxide in the mainstream smoke of a cigarette
US20030185910A1 (en) 2002-02-08 2003-10-02 Taik Koo Yun Cancer preventive composition comprising ginsenoside glycosides of red ginseng
US6936283B2 (en) 2003-07-25 2005-08-30 Langeland Bjoern T. Composition for stimulation of specific metallo-enzymes
US7186517B2 (en) * 2003-08-01 2007-03-06 Aesgen, Inc. Compositions and methods for monitoring breast cancer treatment
EP1660107A4 (en) * 2003-08-18 2008-06-04 Yuyu Inc GINSENG PREPARATION USING VINEGAR AND MANUFACTURING METHOD THEREFOR
KR20050081247A (ko) * 2004-02-12 2005-08-18 이처준 홍삼 및 흑삼을 이용한 해장국 제조 방법.
WO2005084392A2 (en) * 2004-03-03 2005-09-15 Convivia 4-methylpyrazole formulations for inhibiting ethanol intolerance
KR100547253B1 (ko) 2004-05-29 2006-01-26 박명환 암 예방 및 치료에 유효한 진세노사이드 유도체
CN1698879B (zh) * 2005-06-21 2010-08-11 蔺益民 具有解酒护肝功能的产品及制备方法和用途
CN101232822B (zh) * 2005-07-29 2012-11-14 蒂马基金会 用于减缓乙醇代谢和用于降低乙醇诱导的疾病风险的组合物

Similar Documents

Publication Publication Date Title
JP2011510075A5 (https=)
TWI440463B (zh) 原人蔘二醇型人蔘皂苷組合物及其用途
ES2655367T3 (es) Bebida que comprende éster de hidroxibutirato y uso médico de la misma
US8372451B2 (en) Compositions and methods for treating depression
CN112351774A (zh) 用于β-羟基丁酸和乙酰乙酸的酮堆叠的组合物和方法
WO2007142286A1 (ja) 疲労軽減剤
JP6166786B2 (ja) 脳機能低下の予防または改善剤
US10624868B2 (en) Bolus dose of hydroxycitric acid with glycerol
TW202317146A (zh) 口腔環境改善用組合物
US20240277750A1 (en) Compositions and methods for treating depression
CN102335204B (zh) 一种中药制剂金水宝丸及其制备方法
JP7162917B2 (ja) 心拍数低下剤
JP5585075B2 (ja) 成長ホルモン分泌促進剤
CN115315258A (zh) 肾功能保护剂
CN109316490B (zh) 一种具有减肥作用的药物组合物、制剂及其应用
JPWO2021062264A5 (https=)
JP2007106703A (ja) 血管障害の予防および治療組成物
US20240122931A1 (en) Methods for treating covid-19 with sepiapterin
JP2009155278A (ja) 高ホモシステイン血症改善剤
TW201918176A (zh) 食品組合物
JP2025172167A (ja) 睡眠の質の改善剤
WO2020080398A1 (ja) アルコール飲料摂取による悪酔い又は二日酔いの抑制剤
CN107669827A (zh) 一种抗高血压的药物组合物及其制备方法
JP2020018215A (ja) 疲労感軽減剤および疲労感軽減用飲食品組成物
KR20130036804A (ko) 오르니친 또는 오르니친 염을 포함하는 성기능 개선용 조성물